Skip to main content
Nykode Therapeutics ASA logo

Nykode Therapeutics ASA — Investor Relations & Filings

Ticker · NYKD ISIN · NO0010714785 LEI · 254900UKQHWYZJD22017 OL Manufacturing
Open in API
Filings indexed 493 across all filing types
Latest filing 2023-09-27 Investor Presentation
Country NO Norway
Listing OL NYKD

About Nykode Therapeutics ASA

https://nykode.com/

Nykode Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company's core is its proprietary Vaccibody™ technology, a modular platform designed to create targeted vaccines. This technology works by linking antigens to a targeting unit, which delivers them directly to antigen-presenting cells. This mechanism is engineered to induce rapid, potent, and long-lasting T-cell and antibody immune responses. Nykode's development pipeline is focused on generating therapeutics for a range of diseases, with a primary emphasis on oncology and infectious diseases.

Recent filings

Filing Released Lang Actions
Nykode Therapeutics - presentation from Capital Markets Day in Oslo
Investor Presentation Classification · 98% confidence The document is titled "CAPITAL MARKETS DAY" and contains detailed presentations, slides, and updates on the company's pipeline (VB10.16, VB10.NEO), technology platform, financial position, and strategic collaborations. It features presentations from key management personnel (CEO, CBO, CSO, CDO, CFO) and discusses clinical trial data (VB-C-02 trial). This format strongly indicates an Investor Presentation (IP) designed to update investors on strategy and progress, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which focuses only on period results. The content is comprehensive and strategic, fitting the definition of an Investor Presentation.
2023-09-27 English
Nykode Therapeutics - presentation from Capital Markets Day in Oslo
Report Publication Announcement Classification · 99% confidence The document is titled 'Company Announcement' and specifically mentions 'Nykode Therapeutics - presentation from Capital Markets Day in Oslo'. It states that the presentation slides are available on the company website and provides a link to an archived webcast of a previous event. This structure—an announcement that presentation materials are available—fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing, release, or publication of company reports or presentations. It is not the presentation itself (which would be IP) but the notice about it. Given the short length (2851 chars) and the explicit instruction to use RPA when a document announces a report's availability, RPA is the most appropriate classification.
2023-09-27 English
Nykode Therapeutics - presentation from Capital Markets Day in Oslo
Report Publication Announcement Classification · 99% confidence The document is titled "Nykode Therapeutics - presentation from Capital Markets Day in Oslo" and explicitly states that the presentation slides from the Capital Markets Day event are available on the company's website. A Capital Markets Day presentation is a detailed presentation for investors focusing on strategy and financials. Since this document is short (2220 chars) and primarily serves to announce the availability of the presentation slides rather than being the slides themselves, it fits the definition of an Investor Presentation (IP) announcement, or more generally, a Report Publication Announcement (RPA) if the presentation itself is the primary deliverable being announced. Given the context of a 'presentation from Capital Markets Day', the most specific classification is Investor Presentation (IP). However, following Rule 2 (Menu vs Meal), since this is an announcement pointing to the presentation slides, RPA is a strong candidate. Comparing IP (Investor Presentation) and RPA (Report Publication Announcement), the content is clearly an Investor Presentation, and the document acts as the announcement for it. Since the content is about the presentation itself, IP is the most accurate content classification, but the format suggests RPA. Given the options, an Investor Presentation (IP) is the core subject matter being distributed/announced. If the slides were attached, it would be IP. Since it announces the availability of the presentation slides, RPA is technically correct per Rule 2. I will classify it as IP because the core subject is the presentation material, which is a key investor document type, and RPA is often used for formal regulatory reports. However, since it is an announcement of presentation slides, RPA is safer based on Rule 2. Let's re-evaluate: The document *is* the announcement of the presentation materials. Therefore, RPA (Report Publication Announcement) is the most appropriate classification based on Rule 2, as it announces the publication of investor materials.
2023-09-27 English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023
Report Publication Announcement Classification · 99% confidence The document is titled "Company Announcement" and specifically invites analysts and investors to a "Capital Markets Day" scheduled for September 27, 2023. It details the agenda, focusing on pipeline updates, technology platform, and strategic vision. A Capital Markets Day presentation is a detailed presentation for investors covering financials, strategy, and market position, which aligns directly with the definition of an Investor Presentation (IP). Although it is an invitation/announcement, the core content is the presentation material itself, making IP a stronger fit than RPA (which is usually just announcing the publication of a standard report like a 10-K or IR). Since the document is an invitation to an event where detailed investor materials will be presented, classifying it as an Investor Presentation (IP) is the most accurate fit among the provided options.
2023-09-25 English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023
AGM Information Classification · 98% confidence The document text clearly outlines an 'AGENDA' for an event featuring presentations by the CEO, CDO, CSO, and CBO, including specific time slots for updates on programs (VB10.16, VB10.NEO) and Q&A sessions. This structure is characteristic of materials distributed for an Annual General Meeting (AGM) or a similar investor/shareholder event where key executives present updates. Given the options, 'AGM Information (Code: AGM-R)' is the most appropriate classification for a detailed meeting agenda.
2023-09-25 English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023
Regulatory Filings Classification · 99% confidence The document is explicitly titled "Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023". A Capital Markets Day (CMD) is an event where management presents detailed updates on strategy, pipeline, and financials to investors and analysts. This aligns best with the Investor Presentation (IP) category, which covers detailed presentations for investors focusing on financials, strategy, and market position. Although it is an invitation, the content describes the substance of the presentation, making it more specific than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since the document details the content to be presented at an investor-focused event, IP is the most appropriate classification.
2023-09-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.